That's important, because the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (united arab emirates). But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're developed to do. This was a development almost no one observed. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment chances in this space, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (first lady). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back perhaps substantially before going higher - the legacy report prediction. I've been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown prediction for 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous fantastic private companies on the edge of striking the public markets And I've been working on a new way for you to invest even prior to these business go public.
This opportunity has been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to schedule your area totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (biotech stock). And when it comes to tech investing, we leave it to the specialists. Fortunately, we have several such experts in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (biotech stocks jeff brown). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential growth and creating extraordinary chances for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. korean actress. But in spite of what many readers may believe, this is a trend that's simply beginning. Although the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown biotech stock). Losing 2 months of manufacturing and sales truly impacts how lots of 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million systems is amazing. More notably, the hold-ups brought on by the pandemic developed a load of pent-up need. Which need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown top stock pick 2021. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its three various stages.
In Phase Two, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services begin to be used (tech predictions). That's when we start to see applications working on 5G networks. Think of things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer season. This starts something of a virtuous cycle: Many people do not really care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open up a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment chances going forward will be enormous. Stepping far from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a similar idea but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well understood. And during that time, there were truly just 3 business operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire market is successfully a greenfield opportunity.
There's room for many business to exist in this area. diplomatic relations. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is very important since the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug treatments produced using this technology. This was among those breakthroughs that nearly nobody saw. But it's going to have extensive implications for treating disease. And, obviously, there will be a lot of financial investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back maybe significantly before going higher. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin - tech stocks. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown predictions 2021. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we could not separately verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent viewpoint on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a number of his finest choices in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully predicted a few of the biggest financial occasions of the past twenty years. Although he does not appear to launch his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have made him legions of devoted fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research offers numerous research services with a wide variety of expertises - tech stocks.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown biotech picks. On its website, Brownstone says its objective is to provide retail investors with professional-grade research: "For too long, the very best investment research has actually not been available to specific investors. It has been typically booked for investment banks, hedge funds, private equity, and high-net-worth clients. diplomatic relations. The mission of Brownstone Research is to make that type of proprietary research study readily available to any investors seeking to gain an edge in the markets. The goal is basic to provide unique and successful investment research discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a bit about the market, you understand that he has a track record as a King Midas of sorts. biotech stock. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown thinks S.A.V. longtime readers. could be "the greatest trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge technologies: artificial intelligence and electrical cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing short of the automobile market's Holy Grail. As you understand, electric lorries and self-driving car stocks have been huge this year, however the Wall Street maker has approved hype without much tangible outcome. In spite of a drastic increase in competition over the previous few years, Brown still believes Musk has the best opportunity of putting it all together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Car, and it could be the future of transport. Essentially, this technology would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the earnings. It sounds insane, however it could be closed than you believe.